drugset / Trial / NCT06845930

Rectal Versus Intramuscular Diclofenac for Pain Relief Following Caesarean Section

NCT06845930

Completed 60 enrolled Assumpta Nnenna Nweke
RandomizedParallel-groupOpen-labelSupportive care

Summary

Caesarean section (CS) is one of the commonest major Obstetric surgeries worldwide and its rate has markedly increased globally. Pain control is an integral part of enhancement of recovery after caesarean section and NSAIDs have been used in combination with opioids for post-operative pain management in recent times. There are sparse data on maternal satisfaction with suppository diclofenac or any data from our centre that compared the intramuscular and rectal routes of diclofenac administration. Hence this study was conceived to compare the efficacy of rectal diclofenac and intramuscular diclofenac as an adjunct to intramuscular pentazocine in the management of post-operative pain in women who have elective caesarean section.

Timeline

Start
2021-04-19
Primary completion
2021-09-18
Completion
2021-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg Rectal
Subject Diclofenac Other / unclassified 100 mg Rectal

Indications

No indication recorded.